| 注册
首页|期刊导航|中国医学创新|HER2阳性乳腺癌治疗的研究进展

HER2阳性乳腺癌治疗的研究进展

范雪娇 吴涛 袁冶

中国医学创新2025,Vol.22Issue(11):184-188,5.
中国医学创新2025,Vol.22Issue(11):184-188,5.DOI:10.3969/j.issn.1674-4985.2025.11.041

HER2阳性乳腺癌治疗的研究进展

Research Progress in the Treatment of HER2-positive Breast Cancer

范雪娇 1吴涛 1袁冶2

作者信息

  • 1. 新疆医科大学附属肿瘤医院乳外一科 新疆 乌鲁木齐 830000
  • 2. 新疆医科大学护理学院 新疆 乌鲁木齐 830016
  • 折叠

摘要

Abstract

HER2-positive breast cancer is a highly aggressive tumor subtype,and its treatment strategies have been a hot topic in the field of cancer research and have undergone significant changes in the past few decades.With the in-depth understanding of HER2-positive breast cancer,treatments for HER2-positive breast cancer are continuously innovating,significantly improving the survival prognosis of patients.This article reviews the latest research progress in the field of HER2-positive breast cancer treatment,including the development of targeted drugs,immunotherapy,cell therapy,and new drugs.

关键词

HER2阳性乳腺癌/靶向治疗/免疫治疗/治疗策略

Key words

HER2-positive breast cancer/Targeted therapy/Immunotherapy/Treatment strategy

引用本文复制引用

范雪娇,吴涛,袁冶..HER2阳性乳腺癌治疗的研究进展[J].中国医学创新,2025,22(11):184-188,5.

中国医学创新

1674-4985

访问量0
|
下载量0
段落导航相关论文